To: Honor+Integrity who wrote (2741 ) 1/11/2000 3:37:00 PM From: Wayne Rumball Read Replies (1) | Respond to of 4792
POST FALLS, Idaho, Jan 11, 2000 /PRNewswire via COMTEX/ -- Lifestream Technologies, Inc. (OTC Bulletin Board: LFST) today announced clearance by the US Food and Drug Administration of the Company's proprietary Internet software accessory, Privalink(TM). Privalink is the first technology that combines a regulated medical device and patient information through an INTERNET portal using industry-standard Smart Cards and high-level encryption. The Privalink(TM) System, developed by Secured Interactive Technologies which was recently acquired by Lifestream, enables healthcare professionals to perform a total cholesterol test, add additional patient health information, perform health risk analysis with the Lifestream Technologies? Cholesterol Monitor, and then return a personalized patient evaluation booklet through the INTERNET in less than 10 minutes. Christopher Maus, Chairman and Chief Executive Officer, of Lifestream stated, "Privalink is the worlds first system connecting a regulated diagnostic device via a Smart Card to an Internet Portal. Our proprietary cholesterol (lipid) diagnostic system (The Lifestream Technologies(TM) Cholesterol Monitor), combined with a smart card, security, the Internet, and database technology, will, for the first time permit healthcare professionals to provide their patients with personalized diagnostic, prognostic and authoritative published recommendations in mere minutes, all with the highest level of security and privacy." "This clearance is a major achievement in healthcare for the public. This proprietary combination of a diagnostic device and our secured INTERNET site will allow professionals to give patients personalized recommendations and care that has until now been impossible. With this final professional clearance, the diagnostic product and operating system positions the company to move into target markets," stated Christopher Maus. "The country and Congress are concerned about the privacy of medical records and their transmission via the INTERNET. Privalink answers those concerns," said Ken Clegg Director of Information Technology, for Lifestream. "Privalink is a proprietary method to ensure that a patient's personal information is separated from his or her medical record in the database. Patients carry a 'key' to that record on their Personal Health Card, which is a personal Smart Card," said Clegg. "While Smart Cards are reasonably new in the United States, particularly for medical information, there are projections that there will be more than 200 million patients carrying these identification cards in Europe by the end of this year. Through the Privalink System, Lifestream is positioned to be a leader as this trend hits the mainstream here in the US." The Privalink System is unique in its use of encryption and data splitting to insure absolute patient confidentiality. Company meetings with Congressional leaders in Washington, DC confirm that the Privalink System will be compliant with INTERNET and medical information privacy legislation now under consideration. The Lifestream Cholesterol Monitor is a hand-held instrument that identifies total cholesterol from just one drop of blood in approximately three minutes. Costing the patient less than $10 per test, the Lifestream Cholesterol Monitor enables healthcare professionals to easily and inexpensively monitor patients' cholesterol and their progress on a cholesterol-lowering regimen. The Privalink system is a subscription-based, closed Internet web site, allowing healthcare professionals to transmit test results and personal health data from the instrument and publish a personal recommendation booklet from scientific literature. Privalink returns a personalized wellness evaluation to the patient and medical information to the healthcare professional within minutes. About Lifestream Technologies, Inc. Lifestream Technologies is a healthcare company that uniquely links Internet information services to its medical diagnostic products through encrypted Smart Cards to aid in the prevention, monitoring and control of disease. The company's first product is the Lifestream Technologies Cholesterol Monitor; a hand-held instrument that provides total cholesterol results in three minutes. Lifestream Technologies received FDA 510(k) clearance to market the instrument to healthcare professionals in October of 1998, the CDC CLIA waiver in March of 1999, and a CE mark for Europe. Communications to the financial community by Lifestream Technologies, Inc. are not intended nor should they be construed as labeling for the company's products. Any learned intermediary or healthcare professional who reads company communications to the financial community should not rely on these communications for decisions to purchase, indications for use or instructions to use the Company's products. This news release may contain information deemed to be forward-looking statements under the law involving risks and uncertainties. The Company's actual results could differ materially from this news release. Additional information about risks of the Company achieving the results suggested by any forward-looking statements may be found under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's 10-K. SOURCE Lifestream Technologies, Inc. (C) 2000 PR Newswire. All rights reserved. prnewswire.com -0- CONTACT: Marie Hirsch of Lifestream Technologies, Inc., 208-457-9409, ext. 1209